In the latest trading session, 5.21 million Pfizer Inc (NYSE:PFE) shares changed hands as the company’s beta touched 0.58. With the company’s most recent per share price at $26.57 changed hands at -$0.17 or -0.63% at last look, the market valuation stands at $150.58B. PFE’s current price is a discount, trading about -18.71% off its 52-week high of $31.54. The share price had its 52-week low at $24.48, which suggests the last value was 7.87% up since then.
Analysts gave the Pfizer Inc (PFE) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.35. If we narrow down to specifics, the data shows that 1 out of 16 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 7 recommended PFE as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Pfizer Inc’s EPS for the current quarter is expected to be 0.71.
Pfizer Inc (NYSE:PFE) trade information
Instantly PFE was in red as seen in intraday trades today. With action 2.63%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 0.16%, with the 5-day performance at 2.63% in the green. However, in the 30-day time frame, Pfizer Inc (NYSE:PFE) is -1.07% down.
The consensus price target for the stock as assigned by Wall Street analysts is 32, meaning bulls need an upside of 16.97% from its recent market value. According to analyst projections, PFE’s forecast low is 32 with 33 as the target high. To hit the forecast high, the stock’s price needs a -24.2% plunge from its current level, while the stock would need to soar -20.44% for it to hit the projected low.
Pfizer Inc (PFE) estimates and forecasts
Year-over-year growth is forecast to reach -1.01% down from the last financial year.
Consensus estimates given by 12 financial analysts project the company’s revenue in the current quarter to hit an average of 14.43B. 11 analysts are of the opinion that Pfizer Inc’s revenue for the current quarter will be 13.54B. The company’s revenue for the corresponding quarters a year ago was 14.88B and 13.28B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -3.03%. The estimates for the next quarter sales put growth at 1.91%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -13.25%. The 2025 estimates are for Pfizer Inc earnings to decrease by -5.28%, but the outlook for the next 5-year period is at -0.61% per year.
PFE Dividends
Pfizer Inc is expected to release its next quarterly earnings report in March. The 6.36% annual yield figure for the share gives it an annual dividend of 1.69. It is important to note, however, that the 6.36% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.
Pfizer Inc (NYSE:PFE)’s Major holders
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.5018% or 424.38 million shares worth $11.87 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. With 179.55 shares estimated at $4.78 billion under it, the former controlled 3.17% of total outstanding shares. On the other hand, Vanguard 500 Index Fund held about 2.62% of the shares, roughly 148.41 shares worth around $3.95 billion.
